Boothbay Fund Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-22,260
Closed -$75K 840
2018
Q4
$75K Buy
+22,260
New +$75K 0.01% 495